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Abstract
The biochemical and metabolic activities of living cells are virtually stopped at 
ultralow temperature and they enter into a suspended state of animation. However, 
as such, exposure of living cells to ultralow temperature is associated with complex 
changes that reduce their survivability following freeze-thawing. Cryopreservation 
is the method for preserving living cells at ultralow temperature at genetically and 
physiologically stabilized state. Cryopreservation of oocytes and embryos is an inte-
gral part of the assisted reproductive technologies with many potential applications. 
Cryobanking of oocytes and embryos derived from genetically superior animals is 
promising for enhancing the outcome of planned breeding programs and conserv-
ing biodiversity of endangered animal species. Cryobanking can also ensure steady 
supply of oocytes and embryos for many downstream applications of assisted 
reproduction such as in vitro embryo production, embryo transfer, production of 
stem cells, and genetic engineering. Tremendous advancements have been made in 
this field over the past 5 decades and several methods have been demonstrated for 
cryopreserving oocytes and embryos in different species. This chapter focuses on 
the fundamental aspects of oocyte and embryo cryopreservation.
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1. Introduction
The extent of metabolic processes and cellular functions of living cells are reduced 
dramatically in response to low temperature [1]. Further, at ultralow temperature, 
the biochemical and metabolic activities of living cells are virtually stopped and they 
enter into a suspended state of animation. Nevertheless, the exposure of living cells 
to ultralow temperature induces complex changes to the cells that are associated with 
its altered physical structure and biophysical processes. These facts indicate that 
living cells can be preserved at ultralow temperature for a long time. However, the 
preserved cells will be able to resume their normal physiological functions following 
recovery, if their physical structure and vitality are protected during the process and 
period of preservation. The methods for preserving living cells at ultralow tempera-
ture essentially employ these principles and the process is known as cryopreservation. 
It is the technique for preserving living cells or tissues at ultralow temperature, typi-
cally in liquid nitrogen (−196°C), at genetically and physiologically stabilized state.
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Preservation of oocytes and embryos is an integral part of the assisted reproductive 
technologies. It allows not only preserving the valuable female germplasm but also the 
rapid induction of genetic merits into population through in vitro fertilization and 
embryo transfer. The mammalian embryos could be cryopreserved successfully for the 
first time in 1972. It was shown that 50–70% of the early stage mouse embryos survived 
freezing to −196°C that required slow cooling and slow warming [2]. Subsequently, 
considerable efforts have been made until now to cryopreserve oocytes and embryos 
in different mammalian species including livestock (Table 1). The field of gamete 
cryobiology has undergone a tremendous advancement during the last five decades.
Cryopreservation of mammalian gamete has many potential applications. 
Cryobanking of oocytes and embryos derived from genetically superior animals is 
promising for enhancing the outcome of planned breeding programs. The tech-
nique is equally important for conserving biodiversity of endangered animal species 
and, valuable and genetically modified laboratory animals. It also ensures steady 
supply of oocytes and embryos for many downstream applications of assisted 
reproduction such as in vitro embryo production, embryo transfer, production of 
stem cells, and genetic engineering.
The underlying effects of cryopreservation on mammalian oocytes and embryos 
have been studied extensively by the scholars worldwide. Several methods have been 
demonstrated for cryopreserving oocytes and embryos in different species and some 
of these methods are real breakthroughs. Currently, devices and consumables required 
for cryopreservation are available commercially from many firms that transform the 
procedure into a routine practice in humans as well as in livestock. In this chapter, the 
fundamental aspects of oocyte and embryo cryopreservation are discussed in detail.
2. Principles of cryopreservation
The process of cryopreservation exposes the cells to very low temperatures for 
preserving their structural and functional entity for a long period of time. As such, 
the freezing of cells results in the formation of both intracellular and extracellular 
sharp ice crystals that damage the cellular membranes and organelles and render the 
cells nonviable. Further, the formation of ice crystals causes osmotic stress to the 
cells that result from the altered concentration of intracellular solutes. Therefore, any 
cryopreservation protocol fundamentally includes steps that prevent and ameliorate 
such damages to cells during freezing. These damages are avoided by controlling the 
temperature during the freezing process and by incubating cells to cryoprotective 
solution [15]. A rapid freezing process helps avoiding the mechanical damage caused 
by the piercing action of ice crystals, and the rise in intracellular solute concentration 
Species Oocyte Embryo
Cow 1992 [3] 1973 [4]
Rabbit 1989 [5, 6] 1974 [7]
Sheep — 1976 [8]
Goat — 1976 [9]
Horse 2002 [10] 1982 [11]
Pig 2014 [12] 1989 [13]
Buffalo — 1993 [14]
Table 1. 
First reported birth from the cryopreserved oocytes and embryos in different livestock species.
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can be avoided by exposing cells to cryoprotectants [15]. Permeating cryoprotective 
agent (CPA) decreases ice formation by replacing the intracellular liquid [16].
Irrespective of the methods, cryopreservation of oocytes and embryos basically 
includes four steps (Figure 1). Step 1: cells are equilibrated in a CPA solution that 
causes water egress from the cells and their dehydration. Replacement of intracellu-
lar water with permeable CPA lowers the freezing point of the intracellular content 
and reduces the extent of intracellular ice crystal formation. Step 2: equilibrated 
cells are cooled to low temperature and then stored in liquid nitrogen (−196°C). The 
cells are actually frozen during this step and, depending upon the cooling methods, 
either small intracellular ice crystals are formed (slow cooling) or the intracellular 
content is transformed into glass-like state bypassing ice crystal formation (vitri-
fication). Step 3: cryopreserved cells are recovered by thawing and warming that 
reverse the frozen state of the cells. Step 4: finally, the thawed and warmed cells are 
Figure 1. 
Steps involved in cryopreservation of oocytes and embryos.
Infertility, Assisted Reproductive Technologies and Hormone Assays
4
equilibrated in the rehydration solution that causes the replacement of intracellular 
CPA with water molecules. Following this step, the preserved cells regain their 
vitality and resume normal physiological processes.
3. Cryoprotectants
CPAs play key roles in protecting the vitality of the cryopreserved cells during 
their processing and storage at ultralow temperature and their subsequent recovery 
with normal physiological functionality. Christopher Polge and his colleagues 
discovered the cryoprotective capabilities of glycerol in the late 1940s that subse-
quently led to the successful cryopreservation of cattle and poultry spermatozoa 
[17]. This discovery introduced a fascinating branch of bio-physical science, the 
cryobiology. CPAs are water-soluble chemical substances with low level of cytotox-
icity that lower the melting point of water. CPAs can be divided into two categories, 
membrane permeating and membrane non-permeating.
Membrane-permeating CPAs are small molecules that easily penetrate the cell 
membranes. During cryopreservation, these agents decrease freezing point and 
prevent cell damage from high electrolyte concentrations. They form linkages with 
the electrolyte molecules and thus act as partial substitute to water [18]. Penetrating 
CPAs also stabilize lipid membranes by hydrogen bonding with the membrane 
lipids, which is especially important under severely dehydrated conditions.
On the other hand, the non-permeating CPAs increase the viscosity of the 
cryopreservation solution generating osmotic gradient across the cell membrane 
and thus withdraw intracellular water [19]. These agents allow effective dehydra-
tion of the cells even in the presence of permeating CPAs at low concentration. 
Additionally, non-permeating CPAs also reduce mechanical stress that occurs 
during cryopreservation [20]. The list of CPAs commonly used for cryopreservation 
of oocytes and embryos is provided in Table 2.
It may be noted that no permeating CPA is completely devoid of the capability 
to induce cell toxicity. Therefore, the use of a single permeating CPA substantially 
increases the possibility of cellular toxicity to the frozen cells, because of their 
high concentration in the cryopreservation solution. In contrast, similar viscosity 
of cryopreservation solution can be achieved by using a combination of permeat-
ing CPAs along with non-permeating cryoprotective agents. In the latter case, the 
Permeating cryoprotectants Non-permeating cryoprotectants
Ethylene glycol Glucose
Dimethyl sulfoxide Sucrose
Propylene glycol Trehalose
Formamide Raffinose
Acetamide Polyvinyl pyrrolidone
Dimethyl acetamide Mannitol
Ficoll
Polyethylene glycol
Polyvinyl alcohol
Bovine serum albumin
Table 2. 
Commonly used cryoprotectants for cryopreservation of oocytes and embryos.
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concentration of a particular permeating CPA would be much lower in the solution. 
Therefore, it is believed that the CPA-mediated toxicity to the cells can be reduced if 
a combination of CPAs is used for cryopreservation.
4. Methods of cryopreservation
Fundamentally, two methods are available for cryopreserving oocytes and 
embryos. These are slow freezing and vitrification. The major differences between 
these two methods are the concentration of CPA used and the rate of cooling of 
sample during the preservation process (Table 3). However, an improved and 
modified version of the traditional vitrification process has been developed later 
that utilizes extremely high cooling rate as compared to the slow freezing or tra-
ditional vitrification procedures (Table 3). This improved vitrification method is 
known as ultrarapid vitrification.
4.1 Slow freezing
The technique of slow freezing was introduced first for cryopreserving oocytes 
and embryos. The technique was developed during the early 1970s [2, 21, 22] 
and it was considered as a gold standard for long for cryopreserving oocytes and 
embryos. In this technique, samples are equilibrated to a concentration gradient of 
Particulars Methods
Slow freezing Conventional 
vitrification
Ultrarapid vitrification
Concentration of 
cryoprotectants
Low, 1–2 M High, 5–7 M Moderate, 3.5–5.5 M
Sample volume >100 μl 50–100 μl ≤5 μl
Cooling procedure Slow and controlled 
cooling with 
the help of a 
programmable 
freezing machine
No freezing 
machine is 
required; samples 
are directly plunged 
into liquid nitrogen
No freezing machine is 
required; samples are directly 
plunged into liquid nitrogen 
or placed onto a surface cooled 
to the temperature of liquid 
nitrogen
Sample processing 
time
Extended, 2–3 h Short, <10 min Short, <10 min
Formation of ice 
crystal
Yes No No
Likely osmotic injury Low High Moderate
Likely CPA-mediated 
toxic injury
Low High Moderate
Likely chilling injury High Low Low
Sample container Conventional  
0.25-ml straw
Conventional  
0.25-ml straw
Container less or specialized 
container other than 
conventional straw
Status of system Closed Closed Closed or open
Requirement of skill Easy to perform Difficult to perform Difficult to perform
Table 3. 
Comparison among the methods of slow freezing, vitrification, and ultrarapid vitrification.
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CPAs (1–2 M final concentration) to minimize chemical and osmotic toxicity and to 
maintain a balance between the factors that influence cell damage [23]. Following 
equilibration, the samples are loaded into straws and cooled at 1–2°C/min to −5 to 
−7°C and then seeded to initiate extracellular freezing. Thereafter, the samples are 
cooled slowly at 0.3–1°C/min until they attain the temperature anywhere between 
−30 and −70°C [24, 25] and finally the samples are plunged into liquid nitrogen for 
storage. The controlled cooling of samples is achieved with the help of a program-
mable freezing machine. During controlled cooling, exchange of water molecules 
takes place between the extracellular and intracellular fluids without adverse 
osmotic effects [26]. Nevertheless, the extracellular and intracellular water precipi-
tate and form ice crystals during slow cooling [27].
4.2 Conventional vitrification
Vitrification is an alternative to the slow freezing technique. This method allows 
solidification of the cell and the extracellular milieu into a glass-like state bypassing 
the formation of ice crystals. The first successful event of vitrification was reported 
in 1985 [16], and ice-free cryopreservation of mouse embryos at −196°C was dem-
onstrated. Thereafter, enormous efforts have been made worldwide to utilize and 
improve this technique for cryopreserving oocytes and embryos in different species. 
Vitrification is now considered to be a proven method of cryopreservation. In this 
technique, cells are incubated in CPA solutions from low to high viscosity, loaded 
into straw, and directly plunged into liquid nitrogen. The process requires much 
greater cooling rate during freezing and high concentrations of CPA as compared to 
slow freezing. There are three important factors that ensure the vitrification process: 
Cryopreservation 
technique
Cooling rate Warming 
rate
Slow freezing 1–2°C/min until −5 to −7°C followed by 0.3–1°C/min until −30 
to −70°C and then plunging sample into liquid nitrogen
250–600°C/
min
Conventional 
vitrification
2000–2500°C/min 250–600°C/
min
Ultrarapid vitrification
Open pulled straw 20,000°C/min 20,000°C/
min
Closed pulled straw 8100°C/min —
Electron microscopic 
grid
180,000°C/min —
Cryoloop 15,000°C/min 45,000°C/
min
Hemi-straw >20,000°C/min —
Cryotop 23,000°C/min 42,000°C/
min
CryoTip 12,000°C/min 24,000°C/
min
Quartz micro-capillary 250,000°C/min —
Glass capillary 12,000°C/min 62,000°C/
min
Table 4. 
Cooling and warming rates of different vitrification methods.
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(1) viscosity of the CPA solution; (2) cooling rate; and (3) sample volume. Thus, a 
delicate balance must be maintained among these factors to achieve successful vit-
rification [1]. Vitrification can be achieved with a CPA concentration of 5–7 M and a 
cooling rate of approximately 2500°C/min [28]. A major advantage of vitrification is 
the low risk of freezing injury, thereby ensuring a sufficiently high cell survival rate.
4.3 Ultrarapid vitrification
Ultrarapid vitrification is the modified and improved version of the conven-
tional vitrification procedure. The concept of ultrarapid cooling for cryopreserving 
oocytes and embryos was introduced by Vajta and his co-workers with their inven-
tion of the open pulled straw [29, 30]. The viscosity of the vitrification medium and 
cooling rate are inversely related. Thus, a medium containing lesser concentration of 
cryoprotectants and other additives can be vitrified efficiently at higher cooling rate. 
Theoretically, vitrification can be achieved with a 1.5 M concentration of any cryo-
protectant, providing a cooling rate of 15,000°C/min is employed [28]. Ultrarapid 
vitrification technique employs extremely high cooling and warming rates as 
compared to the slow freezing or conventional vitrification methods (Table 4). It 
allows vitrification of relatively low concentration of CPA solution using extremely 
high cooling rate and thus reduces the CPA-mediated toxicity and osmotic stress to 
the vitrified cells. The ultrarapid cooling rate is achieved by reducing the effective 
volume of the solution to be vitrified. At present, this method is considered to be the 
most superior, and high post freeze-thaw survival of oocytes and embryos has been 
demonstrated using this method in different mammalian species.
5. Cryoinjury
Oocytes and embryos are susceptible to different types of injuries following 
cryopreservation, which are collectively known as cryoinjuries. The extent of 
cryoinjuries to the frozen oocytes and embryos depends on many factors. The 
major factors are the type of CPA and freezing technique used for cryopreservation 
and the physiological quality, chilling sensitivity, plasma membrane permeabil-
ity, tolerance for osmotic stress, developmental stage, and species of the oocytes 
and embryos [26, 31]. One of the primary focuses during the development of 
cryopreservation protocols is to minimize the possibilities of cryoinjuries to the 
preserved oocytes and embryos following freeze-thawing. The different types of 
cryoinjuries that oocyte and embryos are exposed to during the cryopreservation 
process are described below.
5.1 Chilling injury
Chilling injuries refer to the irreversible changes that occur to the intracellular 
lipid droplets, lipid-containing membranes, and the cytoskeleton, during the 
cooling phase between +15 and −5°C [32]. Such injuries are commonly associated 
with the slow freezing technique. In contrast, the vitrification method substantially 
reduces the chances of chilling injuries to the frozen oocytes and embryos as they 
are exposed very briefly to the dangerous temperature zone due to high cooling 
rate [33]. Therefore, effective cryopreservation of porcine embryos containing 
extremely large amounts of chill-sensitive lipid droplets can be achieved only 
through vitrification [34]. Similarly, high survivability of cryopreserved oocytes of 
various other species such as cattle, sheep, and horse that are sensitive to chilling 
could be achieved through vitrification [35].
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5.2 Formation of ice crystal
The formation of ice crystals during cryopreservation is the major source of 
cryoinjury [36]. The slow freezing method induces ice crystal formation in the 
aqueous phase surrounding cells as well as inside the cells including the cytoplasm 
and nucleus at the temperature zone between −5 and −80°C. In contrast, high CPA 
concentration and rapid cooling rate of vitrification method allow solidification of 
intracellular and extracellular water into a glass-like state bypassing the formation 
of ice crystals.
5.3 Fracture damage
Fracture damages to the zona pellucida and blastomeres of oocytes and embryos 
are commonly observed following cryopreservation. Such damages usually occur 
during freezing because of the mechanical effect of the solidified solution at the 
temperature zone between −50 and −150°C [37].
5.4 Formation of multiple asters
Aster formation is a newly discovered form of cryoinjury. It is frequently 
observed in the vitrified-warmed and fertilized oocytes [38]. This cryoinjury is 
likely accountable for the loss of ooplasmic function responsible for normal micro-
tubule assembly. The exposure of oocytes to high CPA concentration and ultrarapid 
cooling during vitrification leads to the formation of multiple asters near the male 
pronucleus. The migration and development of pronuclei are disrupted by the asters 
resulting in delayed first cleavage and reduced blastocyst development [38].
5.5 Osmotic stress
During the pre-freezing stage of cryopreservation, incubation of cells with 
high osmolar cryoprotectant solution causes cell shrinkage due to the outward 
movement of intracellular water in response to the difference in osmotic pressure 
between intracellular and extracellular solutions. Similarly, at the stage of thawing 
and CPA removal, the movement of water molecules occurs at the reverse direc-
tion that causes cell swelling. These phenomena are known as osmotic stress. The 
frozen cells are more permeable to water than cryoprotectants as compared to their 
fresh counterpart [39]. Therefore, the cryopreserved cells are more susceptible to 
osmotic stress as compared to the non-cryopreserved cells. The vitrification method 
employs considerably high concentration of CPAs and therefore induces greater 
osmotic stress as compared to the slow freezing technique. It may be noted that the 
required CPA concentration for vitrification is inversely related with the cooling 
rate. Therefore, a practical approach to reduce osmotic stress and CPA-mediated 
cell toxicity during vitrification is to increase the cooling rate and simultaneously 
reduce the concentration of CPAs.
6. Deleterious effects of cryopreservation
Cryopreservation of oocytes and embryos is associated with several deleterious 
consequences that in turn exert negative effects on their post freeze-thaw surviv-
ability and development.
Osmotic shock during cryopreservation and thawing may result in excessive 
shrinkage or swelling of cells that can damage the cellular cytoskeleton and in turn 
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the post freeze-thaw survivability and developmental ability of the cryopreserved 
cells. Similarly, the formation of intracellular ice crystals during freezing may dam-
age the cellular cytoskeleton and cell organelles.
Mitochondria are the most abundant organelles in mammalian oocytes and 
embryos and they are the sole source of energy production. Mitochondrial dysfunc-
tion or abnormalities are critical for the development of oocytes and embryos. A 
reduction in the production of ATP by mitochondria is associated with the devel-
opmental failure of oocytes and embryos [40]. Cryopreservation may contribute 
to mitochondrial dysfunction, mitochondrial swelling [41, 42], abnormally shaped 
mitochondria, rupture of mitochondrial membranes [43, 44], and reduced cellular 
ATP content that might contribute to poor oocyte and embryo development follow-
ing freeze-thawing [45, 46].
It is evident that cryopreservation incurs negative effect on the expression of 
genes associated with oxidative stress, apoptosis, cell developmental process, and 
sperm-oocyte interaction [31, 47]. Such alteration in gene expression is one of the 
contributory factors of cryopreservation toward poor developmental ability of 
cryopreserved oocytes and embryos.
Cryopreservation can be a potential cause of physical damage to DNA. The 
fragmentation of DNA increases in mouse and bovine oocytes following vitrifica-
tion [48, 49]. It is suggested that slow freezing as well as vitrification affect the 
DNA integrity in embryos [50]. Further, cryoprotectants such as ethylene glycol 
and propanediol increase DNA fragmentation in porcine embryos, even without a 
cycle of freezing and thawing [51].
Cryopreservation may induce epigenetic changes in the genome of cryopre-
served oocyte and embryos. Vitrification reduces or increases gene methylation in 
bovine and mouse oocytes and embryos [52–55]. Further, several reports indicate 
that vitrification significantly alters acetylation patterns in oocytes [56, 57]. It is 
suggested that the aberrant epigenetic modifications in response to cryopreserva-
tion are at least partially responsible for the reduced developmental competence of 
frozen oocytes and embryos [31].
7. Difficulties associated with oocyte cryopreservation
The cryopreservation of oocyte is more challenging than that of the embryos. 
As compared to an embryo, an oocyte has to maintain integrity of many of its 
unique structural features following freeze-thawing to undergo fertilization and 
further development. Oocyte being a single cell is more vulnerable to the steps of 
cryopreservation as compared to a multi-cellular preimplantation embryo. The 
larger volume of oocyte decreases the surface-to-volume ratio that makes it very 
sensitive to chilling and intracellular ice formation [58, 59]. The plasma membrane 
of matured oocytes has a low permeability coefficient, thus making the movement 
of cryoprotectants and water slower [60].
In oocytes, the meiotic spindles play crucial roles in meiotic progression as 
well as chromosomal alignment and segregation [61]. Severe disorganization or 
disappearance of meiotic spindles is evident following slow freezing as well as 
vitrification with a more deleterious effect of the slow freezing procedure [31]. 
Cryopreservation exerts a negative influence on microfilament functions in oocytes 
that in turn can lead to abnormal distributions of mitochondria in the oolemma  
[6, 62, 63]. This consequently may result in reduced meiotic competence and fertil-
ization ability of oocytes and developmental failure of early stage embryos.
During cryopreservation, CPA causes transient increase in the intracellular 
concentration of calcium in oocytes [64] that triggers exocytosis of cortical 
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granule [65] resulting in hardening of zona pellucida and in turn compromised 
sperm penetration and fertilization [66].
8. Future perspectives
The procedures of oocyte and embryo cryopreservation have evolved signifi-
cantly since it was demonstrated for the first time five decades ago. Nevertheless, 
the success of oocyte cryopreservation is considerably poor as compared to that of 
the embryos at late developmental stage, even following the ultrarapid vitrification, 
which is considered as the best technique at present. Therefore, currently, the most 
important challenge in this field is to develop standardized protocols for effective 
cryopreservation of oocytes and early stage embryos. The theoretical target of suc-
cess of such protocols should be comparable with that of their non-cryopreserved 
counterpart. It is evident from the current state of knowledge that the ability of 
oocytes and embryos to withstand cryopreservation process varies among the 
different species. It appears impossible to develop a single standardized protocol 
for all species. Therefore, future efforts should focus on developing species-specific 
optimized protocols for oocyte and embryo cryopreservation. Further, it will be 
fascinating to observe future efforts for the development of automated devices for 
oocyte and embryo vitrification. The implementation of an efficient and automated 
ultrarapid vitrification system for routine use in livestock can revolutionize the field 
worldwide. Conclusively, the most prominent future targets of cryopreservation are 
expected to focus on the development of protocols that would maintain as much as 
possible the structural and functional integrities of oocytes and embryos follow-
ing freeze-thawing. The outcome of such protocols should be reproducible as well 
across the laboratories worldwide. Realization of such targets would definitely lead 
to the development of standardized and optimized methods for oocyte and embryo 
cryopreservation for routine use in livestock.
9. Conclusions
Cryopreservation is the technique to preserve living cells at ultralow tem-
perature, typically in liquid nitrogen (−196°C). Cryopreservation of oocytes and 
embryos is extremely important for propagation and conservation of genetically 
superior germplasm. Any cryopreservation protocol basically includes three major 
steps such as equilibration of cells to concentrated solution of cryoprotective agent, 
cooling and storage of cells to ultralow temperature, and recovery of frozen cells 
following thawing and warming. Cryoprotective agents protect vitality of the cryo-
preserved cells during processing and storage at ultralow temperature. Basically, 
there are two fundamental methods for cryopreserving oocytes and embryos, 
slow freezing and vitrification. The slow freezing method involves cooling of the 
samples slowly at controlled rate and formation of intracellular and extracellular ice 
crystals. In contrast, the conventional vitrification method involves rapid cooling 
of the samples and solidification of the cells including extracellular milieu into a 
glass-like state bypassing ice crystal formation. Ultrarapid vitrification is the modi-
fied and improved version of the conventional vitrification procedure that involves 
extremely high cooling and warming rates. Currently, ultrarapid vitrification is 
considered to be the more superior method than slow freezing or conventional 
vitrification. It is evident that cryopreservation often results in different types 
of cryoinjuries such as chilling injury, formation of ice crystal, fracture damage, 
osmotic stress, and formation of multiple asters. The quantum of cryoinjuries to 
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frozen cells depends on many factors. Cryoinjuries are responsible for poor surviv-
ability of the cryopreserved cells. The cryopreservation process is associated with 
several other deleterious consequences and those in turn exert negative effects on 
the post freeze-thaw survivability of the frozen cells. Cryopreservation of oocytes 
is more difficult and yields poor success because of their larger volume and unique 
structural features as compared to that of the embryos. The procedures of oocyte 
and embryo cryopreservation have evolved significantly over the past five decades. 
Yet, the species-specific optimized cryopreservation methods with reproduc-
ible results are not available currently, especially for the oocytes and early stage 
embryos.
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